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Background: To test the hypothesis that a semi-quantitative echocardiographic calcium score (eCS) significantly
correlates with cardiac calcium measured by coronary computed tomography angiography (CCTA) and, secondarily,
severe coronary artery calcifications and stenosis.
Methods: This is a retrospective, observational study, conducted in a tertiary centre. eCS was compared with CCTA
scores of non-coronary cardiac calcium (nCACS), coronary cardiac calcium (CACS) and number of diseased coronary
vessels, in 141 subjects without known coronary artery disease (CAD), who underwent both echocardiography and
CCTA for clinical reasons.
Results: Age, prevalence of hypertension and all measures of calcium (eCS, nCACS and CACS) differed significantly
between the no-CAD and CAD subgroups. eCS was positively correlated with nCACS (Spearman rho = 0.64, p < 0.0001),
CACS (rho = 0.46, p < 0.01) and weakly with the number of diseased coronary vessels (rho = 0.28, p < 0.05). eCS and
nCACS had similar area under the curve (AUC) for the prediction of severe CACS (≥400) (0.77, 95% CI 0.68-0.86 and
0.79, 95% CI 0.72-0.88) or obstructive CAD (0.63, 95% CI 0.54-0.72 and 0.63, 95% CI 0.55-0.73).
Conclusions: eCS, a calcium score easily obtainable during standard echocardiography, is moderately to strongly
correlated with nCACS by CCTA. The full eCS score correlates with nCACS better than its single components. It
correlates with CACS and predicts severe coronary calcification (CACS > 400), a known predictor of cardiovascular
morbidity and mortality. The eCS also predicts obstructive CAD, incrementally to age and clinical variables, although for
this purpose CACS remains the most accurate score.
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Coronary artery calcifications are strongly correlated with
atherosclerosis and the coronary artery calcium score
(CACS) by coronary computed tomography angiography
(CCTA) can be used to make better prediction regarding
the individual risk of future coronary events [1-4].
Using CCTA, the presence of aortic valve calcification
(AVC) and mitral annulus calcification (MAC) has been
associated with CACS [5,6] presence, extent, and vulner-
able characteristic of coronary plaque [7]. Similarly,
AVC, MAC or other semi-quantitative scores of cardiac* Correspondence: ngaibazzi@gmail.com
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unless otherwise stated.calcium using echocardiography have also been associ-
ated with coronary artery disease (CAD) and, more im-
portantly, adverse cardiac prognosis [8-19].
Cardiac calcifications have been historically recognized
since the early days of ultrasound imaging [20], but only
recently the correlation between cardiac non-coronary cal-
cium measured either by echocardiography or CCTA was
investigated, in a small group of 41 subjects [21]. While
CCTA remains the reference method to quantify coronary
and non-coronary cardiac calcium, the use of echocardi-
ography for this purpose, if validated against CCTA,
would portend inherent advantages of low-cost, portability
and radiation safety, becoming a potentially simple adjunct
to clinical scores for individualized risk prediction.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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cardiographic calcium score (eCS) significantly correlates
with cardiac calcium measured by CCTA, we compared
it with CCTA generated scores of non-coronary cardiac
calcium (nCACS), and secondarily with CACS and num-
ber of diseased coronary vessels, in a wide cohort of sub-




Patients who underwent a clinically indicated CCTA be-
tween January 2012 and September 2013 were identified.
Patients with known CAD or previous coronary events
or suspect of cardiac neoplastic mass as an indication
were excluded. Patients with pacemaker leads, sternal
wires or prosthetic valves were also excluded from the
study because usually these are patients with a high
prevalence of CAD or other heart disease.
Echocardiography database was then searched to iden-
tify those patients who also had an echocardiogram per-
formed within 3 months of their CCTA scan. Both the
echocardiograms and CCTA scans were read separately
and independently by 2 different observers (LA, CB)
who were unaware of the results of the other test.
Hypertension was defined as systolic blood pressure
>140 mmHg and or diastolic pressure >90 mmHg or
current use of antihypertensive medications. Diabetes mel-
litus was defined as a history of oral hypoglycaemic drugs
or insulin use or fasting blood glucose levels ≥126 mg/dl.
Tobacco use was defined as currently smoking cigarettes.
Family history was defined as CAD in first degree relatives,
in men <55 y/o and women <65 y/o. Hypercholesterolemia
was defined as history of total cholesterol >200 mg/dl or
use of cholesterol lowering drugs and obesity as a body
mass index > 30.
Computed tomography
The study was performed with a Definition Flash system
(Siemens, Forchheim, Germany). This CT system has two
X-ray tubes and two detector arrays rotating in the same
plane with an angular offset of 95°. Gantry rotation time is
280 ms, which provides a temporal resolution of 75 ms
using a heart rate independent single-segment reconstruc-
tion and high pitch up to 3.4. Detector collimation is 2 ×
64 × 0.6 mm. A z-axis flying focal spot is applied which re-
sults in an acquisition of 2 × 128 slices per rotation.
Two scans were performed in all patients: one to visu-
alise coronary artery calcium and one angiography scan.
CACS: First patients underwent nonenhanced prospect-
ive electrocardiography (ECG)-gated sequential scan to
measure CACS. The corresponding images for calcium
scoring were reconstructed with a slice width of 2.5–
3 mm and slice interval of 1.25–1.5 mm and the tubevoltage was 120 kVp. A region of interest was drawn over
the areas of calcification and the Agatston score was auto-
matically calculated by the software. A cutoff value above
130 Hounsfield units to define calcification and lesion area
multiplied by a density factor derived from the maximal
Hounsfield units [22]. Separate scores were calculated for
the aortic root, aortic valve, mitral valve, papillary muscles,
and for the coronary arteries. For the calculation of aortic
root calcium, only calcifications extending up to 2 cm
above the sinus of Valsalva were used, since this is the level
most often imaged by transthoracic echocardiography. Any
calcification, seen as a ring, or part of a ring at the aortic
annulus was included in the aortic root and not as coronary
or aortic valve calcium. Non-contrast scans used to assess
CACS were compared with contrast-enhanced scans as
well. Contrast-enhanced scans were reconstructed in mul-
tiple views.
CTCA: All scans started above the carina and ex-
tended to just below the diaphragm, including the entire
coronary tree. Scans were done with breath held in
inspiration.
A bolus of iodinated contrast material (Iomeron 400
Bracco Imaging SpA, Milan, Italy) was injected (flow rate,
6.0 mL/sec) followed by a saline chaser with the same flow
rate. To synchronize acquisition of the coronary CTA data-
set to arterial enhancement, a “test bolus” protocol was
used. CTCA was performed with adaptive electrocardio-
graphic (ECG) pulsing which preserves diagnostic image
quality and performance. A prospective ECG-triggering
high-pitch spiral mode or retrospective ECG gating
spiral mode were used. All images were reviewed on a
workstation (Leonardo Siemens) equipped with a dedi-
cated software tool for calcium scoring (Calcium Scoring
CT, Siemens), using multiple windows so that circumflex
coronary artery calcification could be delineated from mi-
tral annular calcification [21].
Effective dose was estimated based on the doe-length
product, using a conversion factor of 0.014 for chest CT
in adults. The estimated effective dose of prospectively
ECG-triggered CTCA using this type of equipment has
been evaluated in average approximately 1–2.5 mSv; if
retrospective triggering is needed, dose is significantly
higher, approximately 10–15 mSv [23].
Echocardiography
All selected patients underwent a standard rest transtho-
racic echocardiography using Philips ie33 system equipped
with S5 probe, within 3 months from CCTA. Criteria for
judging AVC, MAC, Aortic root and papillary muscle cal-
cium were similar to grading systems used in previous
studies [9,16] and are detailed in Table 1. AVC was defined
as focal areas of increased echogenicity and thickening of
the aortic valve leaflets in the absence of aortic stenosis
(velocity across the valve <2.5 m/sec). Each aortic valve
Table 1 Grading system of cardiac and aortic root









0 Absent Absent Absent Absent




3 Severe >10 mm Severe
Aortic valve sclerosis graded as follows: Absent = Normal cusp thickness
(<2 mm), and normal reflectivity; Mild = Cusp thickness >2 mm and/or
increased reflectivity; Moderate = Thickness >4 mm and/or diffuse or focal
cusp hyperreflectivity; Severe = Thickness >6 mm and/or marked
echoreflectivity. Final score was graded from 0 to 8.
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cording to leaflet thickening and calcific deposits; the
highest score for a given cusp was assigned as the overall
degree of aortic valve sclerosis. MAC was defined as an in-
tense and bright echo-producing structure located at the
junction of the atrioventricular groove and posterior mi-
tral valve leaflet and was measured from the leading anter-
ior to the trailing posterior edge and judged on a scale of 0
(normal) to 3 (severe). Papillary muscle calcium was de-
fined as a bright echo involving the head of 1 or both pap-
illary muscles. Aortic root calcium was defined as a focal
or diffuse area of increased echoreflectance and thickening
in the aortic root on the parasternal long-axis view. Ac-
cordingly, a final score was derived as the sum of all iden-
tified cardiac calcific deposits and was in the range of 0
(no calcium visible) to 8 (extensive cardiac and aortic root
calcific deposits).Statistical analysis
Continuous variables are presented as mean ± standard de-
viation, if normally distributed, or median and interquartile
range (IQR) if non-normally distributed; number and per-
centages are presented for categorical variables. CACS,
nCACS score and eCS were not normally distributed,
therefore we conducted our analyses using non-parametric
tests. Furthermore, due to the non-linear relationship be-
tween the variables analyzed, we used Spearman's coeffi-
cient (rho) to test the correlation between 2 variables
among eCS, CACS, nCACS scores and number of diseased
vessels measured by CCTA. Receiver-operator characteris-
tic (ROC) curves were used to evaluate the ability of the
eCS and to identify the best cut-off to predict the presence
of severe CACS (≥400) and obstructive CAD at CCTA in
at least 1 vessel. In addition, ROC curve analysis was
performed to evaluate the ability of nCACS and CACS
to predict the presence of obstructive CAD. A two-tailed
p value <0.05 was considered statistically significant. Stat-
istical analyses were performed using Statsdirect ltd statis-
tical software, Cheshire, UK.Results
Clinical characteristics, eCS and CCTA data in the entire
study population
Out of the 288 CCTA scans performed in the study period
with an available evaluation of coronary artery tree, 147 pa-
tients were excluded because of either known CAD (n = 32),
previous cardiac events (n = 45), evaluation of cardiac
suspect neoplastic mass (n = 21), pacemaker leads creat-
ing artifacts (n = 3) or unavailability in our database of
an echocardiogram performed within 3 months (n = 46).
A final study group of 141 subjects was produced. Me-
dian age was 67 y/o (IQR 58–75) with male gender repre-
senting 57% of the population; 66% were hypertensive,
55% hypercholesterolemic, 30% were active smokers and
14% diabetics.
Most subjects were intermediate-risk patients under-
going CCTA for evaluation of coronary artery tree; indi-
cations to CCTA were: suspected CAD in 118 patients
(84%), planning of atrial fibrillation ablation procedure in
15 (11%) and other indications (risk stratification before
aortic artery surgery, or dilated cardiomyopathy of un-
known etiology) in 8 (5%). Using a >50% diameter stenosis
to define obstructive CAD at CCTA, patients with no
CAD, single-vessel, 2-vessel or 3-vessel disease were 86
(61%), 32 (23%),13 (9%) and 11 (7%), respectively; accord-
ingly, 61% had no obstructive CAD, while 39% had at least
one diseased (>50% stenosis) coronary artery.
Among demographics and risk factors, only age and
prevalence of hypertension differed significantly between
the CAD and no CAD subgroups; while eCS, nCACS and
CACS all differed significantly between the CAD and no
CAD subgroups groups (Table 2). Figure 1 graphically de-
picts the frequencies distribution of eCS values in the en-
tire study population.
Reproducibility of eCS
A total of 40 echocardiographic exams were randomly
selected and analyzed again 1 month later by a second
observer to assess interobserver agreement for the eCS.
According to weighted K test, interobserver agreement
was good (weighted K = 0.78).
Correlation data
Table 3 shows correlation data for all possible couples of
variables among eCS, nCACS, CACS and the number of
diseased vessels at CCTA.
Correlation between eCS and nCACS
The comparison between total eCS and the corresponding
CCTA-derived cardiac score (nCACS), which was the pri-
mary aim of the study, yielded a positive and significant
correlation (Spearman rho = 0.64, p < 0.0001), representing
a strength of correlation usually defined as moderate or
strong. Single components of the eCS or their partial
Table 2 Baseline demographics and clinical variables, echocardiography and computed tomography scores both in the
entire population and in the subgroups with or without obstructive coronary artery disease
Entire population (n = 141) CAD > 50% (n = 55) No CAD > 50% (n = 86) p
Age, median (IQR) 67 (58–75) 71 (61–80) 65 (55–73) <0.01
Male gender (%) 80 (57%) 31 (56%) 49 (57%) ns
Hypertension (%) 93 (66%) 46 (84%) 47 (55%) <0.01
Family history of CAD (%) 47 (33%) 22 25 ns
Smoking (%) 43 (30%) 17 26 ns
Hypercolesterolemia (%) 77 (55%) 32 45 ns
Diabetes (%) 20 (14%) 11 9 ns
Obesity (%) 12 (8%) 4 8 ns
n. of vessels CAD > 50% (0-1-2-3) 86-32-13-11 - - -
eCS > 1 35 (25%) 22 (40%) 13 (15%) <0.01
eCS, median, IQR, (range) 1, 0–1, (0–6) 1, 1–2, (0–6) 1, 0–1, (0–5) 0.015
CACS, median, IQR, (range) 29, 0–294, (0–3316) 294, 47–618, (0–3316) 3, 0–46, (0–1109) < 0.001
nCACS, median, IQR, (range) 0, 0–97, (0–4377) 54, 0–178, (0–4377) 0, 0–65, (0–2936) < 0.01
CAD = coronary artery disease, eCS = echographic calcium score, nCACS =multidetector computed tomography non-coronary artery calcium score, CACS = coronary
artery calcium score, IQR = interquartile range.
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MVC rho = 0.50, AVC rho = 0.49, aortic root calcium
rho = 0.42, MVC rho = 0.32, p < 0.001 for all), or did not
correlate as it was the case for papillary muscle calcifi-
cation (p = 0.13).
Correlation between eCS and CACS
Comparing eCS with the CACS also showed a significant
positive correlation, but the strength of such correlation
was inferior in magnitude compared to eCS and nCACSFigure 1 Frequency distribution of echographic calcium score (eCS) in
lowest scores. Only one patient had a score = 6 (corresponding bar not vi
severe eCS of 7 or 8 points.with rho = 0.46 (p = 0.0026), which is usually defined as
moderate to low correlation.
Correlation between either eCS, nCACS or CACS with CAD
When eCS was correlated with the number of diseased
vessels at CCTA, there was a weak to low correlation
(rho 0.28, p < 0.05) only when the most severe definition of
CAD (diameter stenosis > 70%) was applied, while nCACS
did not correlate with the number of diseased vessels, what-
ever the definition of obstructive CAD utilized. CACSthe study population, showing the skewed curve towards
sualized in the graph due to scale), while no patient had the most
Table 3 Correlation data
Correlation, rho, p value nCACS CACS Number of vessels > 50% Number of vessels > 70%
eCS 0.64, p < 0.0001 0.43, p < 0.0001 ns 0.28, p < 0.05
nCACS - - ns ns
CACS 0.51, p < 0.0001 - 0.44, p < 0.001 0.29, p < 0.05
eCS = echographic calcium score, nCACS =multidetector computed tomography non-coronary artery calcium score, CACS = coronary artery calcium score.
Gaibazzi et al. Cardiovascular Ultrasound 2014, 12:43 Page 5 of 9
http://www.cardiovascularultrasound.com/content/12/1/43correlated with the number of diseased vessels also (and
more robustly than >70%) when the definition of milder
disease, i.e. stenosis > 50%, was used. Only 12 pts had at
least one >70% stenosis and consequently this definition
of CAD was not further analyzed, due to lack of statis-
tical power.
Prediction of severe coronary calcification (CACS ≥ 400)
and obstructive CAD
ROC curves (Figure 2, upper part) demonstrate that eCS
or AVC +MVC had similar capability (AUC 0.77 andFigure 2 Receiver operatore curve (ROC) plots for (left) the prediction
echographic score (eCS), selected components (AVC or MVC) and the
eCS and combined AVC +MVC, while >0 for the separate component
coronary calcifications (CACS ≥ 400) (mid) or eCS, nCACSA and CACS for pr
valve calcification, CACS = coronary artery calcium score calcifications, CAD
calcium score, nCACS = non-coronary artery calcium score.AUC = 0.78, respectively) to predict a high CACS score,
while AVC (AUC 0.74) and MVC (AUC 0.67) alone had
slightly lower AUC values. Figure 2 (lower table) shows
all AUC data and related best cutoffs for the prediction
of either CACS ≥400 or obstructive CAD.
eCS and nCACS had similar accuracy for the prediction
of both a high CACS ≥400 or obstructive CAD (at least
one >50% stenosis) (Figure 2, lower part). Regarding the
prediction of obstructive CAD, CACS had the highest pre-
dictive power when compared with both methods of car-
diac non-coronary calcium assessment (nCACS and eCS).of severe coronary calcification(CACS ≥ 400) by total
ir combination (MVC + AVC); best cutoff was >1 point both for
s (either AVC or MVC). Assessment of eCS and nCACS for severe
esence of obstructive CAD (right). AUC = Area under curve, AVC: aortic
= coronary artery disease, CI = confidence interval, eCS = echographic
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regression models significantly increased when adding
eCS to age and clinical variables (global chi square 28.2
vs 20.6, p < 0.01) and further when finally adding CACS
score (global chi square 46.7 vs 28.2, p < 0.001).
Discussion
This study is the first to report data on eCS, nCACS,
CACS and obstructive CAD in the same group of pa-
tients, whereas parts of these data were separately ad-
dressed in few previous studies [9,10,21].
The main finding in our study is that a calcium score
(eCS), easily obtained from a standard echocardiographic
examination is moderately to strongly correlated with
cardiac non-coronary calcium score (nCACS). Further-
more, the full eCS score correlated better with nCACS
than single components of the score itself (AVC, aortic root
calcium, AVC+MVC and MVC). Finally, eCS also corre-
lates with CACS and, in particular, it nicely predicts the
presence of severe coronary calcification (CACS ≥ 400), a
well-known predictor of future cardiovascular morbility
and mortality, with a similar area under the curve com-
pared with the corresponding non-coronary (nCACS) score
by CCTA imaging. The eCS also significantly predicts the
presence of obstructive CAD, and does so incrementally to
age and clinical variables, but for this specific purpose, as
expected, CACS remains more accurate.
Breaking the calcium score into pieces
Although AVC, aortic root calcification or the combin-
ation of AVC+MVC correlated with total nCACS almost
as well as full eCS, MVC was inferior for this purpose and
papillary muscle calcification was instead not correlated at
all. When analyzing the correlation of each single compo-
nent of the eCS with the corresponding component of theFigure 3 Incremental value for the prediction of CAD > 50%. Predictio
score was the best addition on top of age, clinical risk factors and eCS, the
prediction of obstructive CAD compared with starting clinical model. CACS
disease, CCTA = coronary computed tomography angiography, eCS = echonCACS (data not shown), the only component which did
not significantly correlate between the 2 imaging
methods was the papillary muscles calcium, which was
scored as present in 20 patients by echocardiography
and in no patient by CCTA. After reviewing those 20
cases, and confirming there were no significant errors
on echocardiography or CTCA reading, the mismatch
may be explained by the limitation of ultrasound in de-
tecting the actual presence of calcium, relying mostly
on thickening and hyperechogenicity, differently from
CCTA specificity, thanks to the use of X-rays. Fibrosis
of cardiac structures cannot be easily differentiated
from calcification using conventional ultrasound im-
aging and this may possibly account for differences be-
tween echocardiography and CCTA in papillary muscles
calcification data, which we hypothesize in fact do rep-
resent fibrosis and not calcification.
Papillary muscles could probably be eliminated from
the eCS, without decreasing the predictive accuracy of
the score itself, although the number of patients in our
study who demonstrated papillary muscles calcification
using ultrasound was too low to draw conclusions.
Cardiac calcifications for either diagnosis of CAD
or prognosis
From a clinical standpoint, a wealth of previous literature
regarding eCS or MVC or AVC assessment convincingly
demonstrates the prognostic value of ultrasound calcium
assessment [11-19], compared with the more elusive diag-
nostic prediction of obstructive CAD [8-10,24,25], for
which clinical purpose other tools, such as CCTA or pro-
vocative testing, may be more useful. One previous study
[9], conducted on the same number and type of patients,
but lacking nCACS data, confirmed the relation between
eCS, CAC and CAD, but found that the best predictiven of at least one coronary stenosis >50% at CCTA. Although the CACS
addition of eCS was also a significant increasing step towards better
= coronary artery calcium score calcifications, CAD = coronary artery
graphic calcium score.
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one point lower (eCS > 1). This confirms the presence of a
grey zone, as in most scores in medicine, between eCS 1
and 2, in which results should be interpreted with clinical
caution. Our study confirms that ultrasound-detected car-
diac calcium, assessed with a simple but comprehensive
score, encompassing left heart valves, aortic root and pap-
illary muscles, does predict obstructive CAD similarly to
nCACS, though the clinical usefulness for CAD diagnostic
purpose is limited by its moderate accuracy, compared
with CACS. On the other hand, our study confirms that
echocardiographic cardiac calcium moderately correlates
with coronary calcium and its prediction of cardiac events,
at least in part, works through prediction of coronary ar-
tery stenosis. Other mechanisms can be hypothesized: in
fact, published data from CCTA studies showed that the
presence of cardiac calcium outside the coronary tree may
not only reflect coronary calcium burden [5,6] but also the
vulnerability of atherosclerotic plaques, acting like a fea-
ture of additional risk for cardiac events, independently
from the presence or grade of a coronary stenosis [7]. This
would explain the robust link between cardiac calcium
and prognosis, in spite of a weaker correlation with coron-
ary artery stenosis grade. A recent study linked coronary
plaque vulnerability to calcium density in the plaque, by
so doing demonstrating that the total burden of coronary
calcium is only part of the cardiac risk picture [26].
What clinical use for eCS?
A hypothetical practical clinical use for the eCS, by
virtue of its higher specificity compared with (lower)
sensitivity value for severely calcified coronaries, which
in turn predict both obstructive CAD and coronary
events, would be to reclassify patients at estimated low or
intermediate clinical cardiac risk, to a higher risk class in
those cases in which eCS is >1 or, even better (to incorp-
orate the best cutoff of a previous similar study), eCS > 2.Figure 4 Computed tomography (left and mid) and echocardiograph
valve calcification and lower panel shows mitral valve calcification.In fact, when raising the cutoff from >1 to >2 points in
our study the specificity of eCS to predict CAD went from
85% up to 93%, but at the obvious expense of sensitivity
becoming trivial (16%). This hypothesis clearly needs pro-
spective validation, which we are currently implementing
in a wide prospective outcome study.
Strengths and limitations
This study is a single-center and retrospective one, po-
tentially subjected to patient selection bias. The retro-
spective identification of patients having both an
echocardiogram and CCTA available forced us to accept
the quality of available echocardiograms, sometimes in-
complete for an ideal calcium assessment; this may be
regarded as a drawback or as a strength of our study,
using “real-life” standard echocardiograms. Comparison
between a semi-quantitative and a fully quantitative ap-
proach is difficult, and the eCS requires some operator
experience to control gain settings in order to obtain re-
producible results; thus, CCTA remains a more objective
approach in this regard (Figure 4 shows examples of cardiac
calcifications imaged both at CCTA and echocardiography).
It is not always possible to distinguish sclerosis from calcifi-
cation, which probably represent two phases of the same
pathophysiologic process; accordingly, in our study sclerotic
lesions were included along with calcified lesions in the
eCS. The non-simultaneity of ultrasound and CCTA exam-
inations is probably a minor drawback, since the 2 tests
were per protocol separated by less than 3 months, a trivial
interval for the chronic atherosclerotic process.
In 2011 Pressmann et al. [21] reported comparable
strength of correlation, in a smaller group of similar pa-
tients with clinical indication to cardiac computer tom-
ography, between their ultrasound score and either
nCACS (rho 0.56 vs 0.64 in our study) or CACS (rho
0.46 vs 0.43 in our study), confirming the trend towards
better correlation with nCACS rather than CACS, whichy (right) parallel imaging of calcifications. Upper panel shows aortic
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the first using the latest technology, 128-slice dual-
source scanner for CCTA, which is the most accurate
non-invasive technology to assess obstructive CAD and
minimizes radiation exposure.
Conclusions
This study demonstrates that cardiac non-coronary cal-
cium by echocardiography correlates well with the same
measure by computed tomography, with severe coronary
artery calcification and, although less strongly, with ob-
structive coronary artery disease.
Echocardiographic calcium score, which is now robustly
validated against non-coronary calcium by computed tom-
ography, might be used as a calcium score to be widely
utilized at low cost and with no irradiation safety issues,
on top of clinical risk score, for individualized refinement
and potential reclassification of cardiac risk. This use
needs to be prospectively tested in multicenter outcome
studies, investigating the risk reclassification potential of
eCS, which could possibly optimize the use of known
disease-modifying therapies, such as statins.
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